ASH: Glofitamab Aids Relapsed, Refractory Diffuse Large B - Cell Lymphoma

39 percent of patients had a complete response, with median time to complete response of 42 days
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Oncology, Pharmacy, Conference News, Source Type: news